These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8857231)

  • 1. A mapping of histology and cell proliferation in human bladder cancer: an immunohistochemical study.
    Igawa M; Urakami S; Shirakawa H; Shiina H; Ishibe T; Usui T; Moriyama H
    Hiroshima J Med Sci; 1995 Dec; 44(4):93-7. PubMed ID: 8857231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of p53 and proliferating cell nuclear antigen (PCNA) in bladder cancer: positive immunostaining and radiosensitivity.
    Ogura K; Habuchi T; Yamada H; Ogawa O; Yoshida O
    Int J Urol; 1995 Nov; 2(5):302-8. PubMed ID: 8749948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1617-31. PubMed ID: 2435127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder.
    Shariat SF; Kim JH; Ayala GE; Kho K; Wheeler TM; Lerner SP
    J Urol; 2003 Mar; 169(3):938-42. PubMed ID: 12576817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Growth fractions of bladder cancer determined by proliferating cell nuclear antigen immunostaining].
    Kuroda H; Yasunaga Y; Takatera H; Fujioka H; Ohnishi A; Tsujimoto M
    Hinyokika Kiyo; 1994 May; 40(5):379-82. PubMed ID: 7912881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights from a whole cystectomy specimen--association of primary small cell carcinoma of the bladder with transitional cell carcinoma in situ.
    Gaisa NT; Tilki D; Losen I; Dahl E; Stoehr R; Stief CG; Knüchel R
    Hum Pathol; 2008 Aug; 39(8):1258-62. PubMed ID: 18547617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apoptosis and expression of PCNA in superficial transitional cell bladder cancer as related to recurrence].
    Chen L; Wang X; Mei H; Chen W
    Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):484-6. PubMed ID: 11825447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
    Serio G
    Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
    Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
    Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder.
    Waldman FM; Carroll PR; Cohen MB; Kerschmann R; Chew K; Mayall BH
    Mod Pathol; 1993 Jan; 6(1):20-4. PubMed ID: 8093979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of different biomarkers (DNA, PCNA, apoptosis and karyotype) in prognostic evaluation of superficial transitional cell bladder carcinoma.
    Lavezzi AM; Biondo B; Cazzullo A; Giordano F; Pallotti F; Turconi P; Matturri L
    Anticancer Res; 2001; 21(2B):1279-84. PubMed ID: 11396199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of proliferating cell nuclear antigen in superficial bladder cancer--application to paraffin-embedded tissue sections].
    Wada T; Shimabukuro T; Kurisu H; Shameem IA; Yoshihiro S; Matsuyama H; Naito K; Hashimoto O; Tanaka K
    Hinyokika Kiyo; 1993 Apr; 39(4):313-9. PubMed ID: 8099249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
    Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
    Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Undifferentiated small-cell carcinoma of the urinary bladder].
    Suárez Vilela D; Salas Valien JS; González Morán MA; Giménez Pizarro A
    Arch Esp Urol; 1991 Dec; 44(10):1195-8. PubMed ID: 1667892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCNA immunostaining as a valid alternative to tritiated thymidine-autoradiography to detect proliferative cell fraction in transitional cell bladder carcinomas.
    Lavezzi AM; Terni L; Matturri L
    In Vivo; 2000; 14(3):447-51. PubMed ID: 10904880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic modeling of human urinary bladder carcinogenesis.
    Czerniak B; Li L; Chaturvedi V; Ro JY; Johnston DA; Hodges S; Benedict WF
    Genes Chromosomes Cancer; 2000 Apr; 27(4):392-402. PubMed ID: 10719370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.